FDA Approves J&J Anti-Clotting Drug

Published November 10, 2012

FDA approves J&J anti-clotting drug

Filed under: drug treatment programs nj

RARITAN, N.J. — The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating internal blood clots, the company said. J&J subsidiary Janssen Pharmaceuticals announced the approval of Xarelto (rivaroxaban) for treating …
Read more on Drug Store News

Merck may not have shown women can safely use bladder drug, regulators say

Filed under: drug treatment programs nj

9 advisory panel meeting to discuss the drug, which Merck is seeking to make the first bladder treatment available without a prescription. … to nonprescription Oxytrol from Watson Pharmaceuticals Inc. The FDA is scheduled to decide on Merck's Oxytrol …
Read more on The Star-Ledger – NJ.com

FDA Approves New 800mg PREZISTA® (darunavir) Tablet

Filed under: drug treatment programs nj

TITUSVILLE, N.J., Nov. 9, 2012 — /PRNewswire/ — Janssen Therapeutics, Division of Janssen Products, LP, announced today the U.S. Food and Drug Administration (FDA) has approved a new 800mg tablet of PREZISTA® (darunavir) for once daily oral …
Read more on Sacramento Bee

alcohol treatment program in new jersey – addiction recovery, drug recovery, treatment centers, drug rehab, alcohol rehab, addiction rehabilitation, alcohol recovery, drug treatment program, alcohol treatment program